Skip to main content
Yirong Zhu, DO, Oncology, Hines, IL, Loyola University Medical Center

YirongZhuDOPhD

Oncology Hines, IL

Breast Cancer, Gastrointestinal Cancer, Genitourinary Oncology, Thoracic Cancer

Hematology and Oncology Fellow

Dr. Zhu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Zhu's full profile

Already have an account?

Education & Training

  • Loyola University Medical Center
    Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 2020
  • Advocate Health Care/Advocate Lutheran General Hospital
    Advocate Health Care/Advocate Lutheran General HospitalResidency, Internal Medicine, 2017 - 2020
  • Michigan State University College of Osteopathic Medicine
    Michigan State University College of Osteopathic MedicineClass of 2017, DO, PhD

Certifications & Licensure

  • IL State Medical License
    IL State License 2019 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Paclitaxel versus docetaxel-based neoadjuvant chemotherapy and risk of lymphedema in breast cancer patients
    Yirong Zhu, Tamer Refaat Abdelrhman, Yvonne Ho, Tarita Thomas, William Small, Constantine Godellas, Faaiza Vaince, Hanh Mai, Journal of Clinical Oncology, ASCO 2021, 5/28/2021

Hospital Affiliations